Lv3
400 积分 2025-12-08 加入
Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study
15天前
已完结
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry
15天前
已关闭
New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities
15天前
已完结
Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension
21天前
已完结
Study of Risk Assessment Scores as Surrogate Endpoints in Pulmonary Arterial Hypertension Trials
21天前
已完结
Improving risk assessment with right ventricular phenotyping in patients with pulmonary arterial hypertension: minimizing future surprises
22天前
已完结
Patient‐Specific Lumped‐Parameter Model for Quantifying Vessel‐Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension
22天前
已完结
Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution
22天前
已完结
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
1个月前
已完结
The Importance of Liver‐Lung Communication in Pulmonary Vascular Diseases
1个月前
已完结
皖公网安备34019202002308
